Dr. Reddy’s signs licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Aarogya program aims to improve the overall health outcomes for the community by offering comprehensive health screenings, diagnostic support, and increased health awareness
Shivani Satish Wagh takes on the role of Joint Managing Director
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Subscribe To Our Newsletter & Stay Updated